Targeted-delivery of chemotherapy (NANOLEUK) vs standard chemotherapy in acute myeloid leukemia: a proposed randomized, double-blinded, multicenter efficacy trial. Principles and Practice of Clinical Research, [S. l.], v. 2, n. 2, 2016. Disponível em: https://journal.ppcr.org/index.php/ppcrjournal/article/view/44.. Acesso em: 7 may. 2024.